No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. Biquard L, Valla D, Rautou PE. J Hepatol 2020;73:717-718.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Biquard L, Valla D, Rautou PE. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. J Hepatol 2020;73:717-718.
PMID: 32360995